A detailed history of Mc Broom & Associates, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mc Broom & Associates, LLC holds 7,137 shares of BMY stock, worth $358,277. This represents 0.26% of its overall portfolio holdings.

Number of Shares
7,137
Holding current value
$358,277
% of portfolio
0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 16, 2025

BUY
$53.9 - $63.11 $384,684 - $450,416
7,137 New
7,137 $435,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $107B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mc Broom & Associates, LLC Portfolio

Follow Mc Broom & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Broom & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Broom & Associates, LLC with notifications on news.